Objective There is no consensus on the definition of a hemodynamically significant patent
ductus arteriosus (hsPDA). In this review article, our objective is to discuss the main …

The ductus arteriosus is likely to close without treatment in most infants born at gestational
age (GA)> 28 weeks (73%), and those with birth weight> 1000 g (94%). However, the rates …

Clinical reports from the American Academy of Pediatrics benefit from expertise and
resources of liaisons and internal (AAP) and external reviewers. However, clinical reports …

Objectives To test the hypothesis that a patent ductus arteriosus (PDA) severity score
(PDAsc) incorporating markers of pulmonary overcirculation and left ventricular (LV) …

Hypotension is a commonly diagnosed and treated complication of extremely low
gestational age newborns (ELGAN), but enormous variation in diagnosis, management and …

Patent ductus arteriosus (PDA) is a common clinical condition in preterm infants. Preterm
newborns with PDA are at greater risk for several morbidities, including higher rates of …

In preterm infants, failure or delay in spontaneous closure of Ductus Arteriosus (DA),
resulting in the condition of Patent Ductus Arteriosus (PDA), represents a significant issue. A …

BACKGROUND AND OBJECTIVES: Echocardiogram is the gold standard for the diagnosis
of hemodynamically significant patent ductus arteriosus (hsPDA) in preterm neonates. A …

Abstracts Equipoise persists as to the issue of assigning haemodynamic and clinical
significance to a patent ductus arteriosus (PDA). The objective was to ascertain whether …

Optimum management of the patent ductus arteriosus (PDA) in preterm infants remains one
of the most debated topics within the field of neonatology. Despite numerous observational …